Anpario (ANP) AI Stock Analysis

• Market Cap: £85.52M
• Dividend Yield: 2.23%
• Average Volume (3M): 40.37K
• Price to Earnings (P/E): 16.6
• Beta (1Y): 1.06
• Revenue Growth: 34.26%
• EPS Growth: 71.40%
• Country: UK
• Employees: 157
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.16
• Shares Outstanding: 20,595,829
• 10 Day Avg. Volume: 28,791
• 30 Day Avg. Volume: 40,371
• PEG Ratio: 0.20
• Price to Book (P/B): 1.80
• Price to Sales (P/S): 1.71
• P/FCF Ratio: 15.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £448.00
• Price Target Upside: -11.29% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 77 Outperform
• Price Target: 448.00p ▼(-11.29% Downside)

Anpario's strong financial performance and positive corporate events are the primary drivers of its stock score. While technical analysis presents mixed signals, the company's fair valuation and strategic initiatives support a positive outlook.

Anpario Business Overview & Revenue Model

Company Description

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salgard, Salkil, Genex, and Optimax brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Salkil, Salgard, Oxigard, Moldgard, and Mastercube brands. The company's hygiene and insect control category contain products, such as water sanitation tablets, 100% natural insect control powders, and natural drying agents that minimizes the environmental microbial burden, supports the gut health, and animal performance under the Credence, Mitex, Red Lite, and Clean & Dry brands; and toxin management category products, such as mycotoxin binders under the Anpro, Ultrabond, and Neutox brands. It has operations in the Americas, Asia, Europe, the Middle East, and Africa. The company was formerly known as Kiotech International plc and changed its name to Anpario plc in November 2011. Anpario plc was founded in 1996 and is headquartered in Worksop, the United Kingdom.

How the Company Makes Money

Anpario generates revenue primarily through the sale of its feed additives and supplements to farmers, livestock producers, and aquaculture operations. The company's revenue model is based on direct sales to customers, as well as distribution agreements with partners across various regions. Key revenue streams include sales of its core product lines, which are designed to improve animal health, growth rates, and feed efficiency. Additionally, Anpario has established significant partnerships with distributors and agricultural companies that expand its market reach, contributing to its earnings. The company also benefits from increasing global demand for natural and sustainable agricultural practices, positioning it well within the industry.

Anpario Financial Statement Overview

Summary

Anpario demonstrates strong financial performance with consistent revenue and profit growth, efficient operations, and a robust balance sheet. The company maintains low leverage and strong equity, although recent trends in operating cash flow should be monitored.

Income Statement

Anpario has demonstrated consistent revenue growth, with a notable increase from 2023 to 2024. The gross profit margin has been stable, and the net profit margin has improved, indicating enhanced profitability. The EBIT and EBITDA margins have also shown strength, reflecting efficient operations. Overall, the income statement reflects solid growth and profitability.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating prudent financial management. The equity ratio is healthy, suggesting a strong capital position. Return on equity is robust, showcasing effective utilization of shareholder investments. The balance sheet reflects financial stability and low leverage risk.

Cash Flow

Anpario's cash flow metrics are positive, with strong operating cash flow compared to net income, indicating good cash generation. Free cash flow has grown, supporting business reinvestment and shareholder returns. The cash flow statement shows effective cash management, although a decrease in operating cash flow in the latest year warrants attention.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	43.93M	38.20M	31.00M	33.10M	33.37M	30.52M
Gross Profit	21.24M	17.34M	13.96M	13.49M	15.53M	15.20M
EBITDA	7.67M	6.38M	4.00M	4.91M	6.98M	6.59M
Net Income	5.14M	4.11M	2.53M	3.30M	4.68M	4.21M
Balance Sheet
Total Assets	48.44M	47.15M	40.19M	48.53M	47.98M	44.48M
Cash, Cash Equivalents and Short-Term Investments	11.10M	10.50M	10.65M	13.57M	15.54M	15.82M
Total Debt	86.00K	74.00K	79.00K	52.00K	85.00K	90.00K
Total Liabilities	9.38M	10.85M	6.54M	7.22M	7.68M	6.97M
Stockholders Equity	39.05M	36.29M	33.65M	41.31M	40.30M	37.51M
Cash Flow
Free Cash Flow	2.22M	4.20M	7.95M	-329.00K	1.78M	4.66M
Operating Cash Flow	4.32M	6.14M	8.70M	1.21M	3.20M	5.92M
Investing Cash Flow	-4.84M	-4.18M	1.21M	-1.44M	-1.42M	-1.26M
Financing Cash Flow	-1.65M	-1.54M	-10.96M	-1.96M	-2.01M	-2.52M

Anpario Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 505.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ANP, the sentiment is Positive. The current price of 505 is above the 20-day moving average (MA) of 493.48, above the 50-day MA of 438.15, and above the 200-day MA of 417.81, indicating a bullish trend. The MACD of 19.44 indicates Positive momentum. The RSI at 72.19 is Negative, neither overbought nor oversold. The STOCH value of 52.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:ANP.

Anpario Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ANP	77 Outperform	£85.52M	16.65	13.81%	2.23%	34.26%	71.40%
HFG	66 Neutral	£590.61M	15.09	12.72%	5.22%	8.58%	-15.81%
GNC	64 Neutral	£994.37M	18.34	12.12%	0.87%	0.49%	14.18%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
UKR	51 Neutral	£2.28M	3.13	-94.96%	―	15.00%	-592.50%

Anpario Corporate Events

Anpario to Present Interim 2025 Results in Live Investor Session

Anpario announced a live presentation of its Interim Results for the first half of 2025, to be conducted by CEO Richard Edwards and Group Finance Director Marc Wilson. This presentation, scheduled for September 11, 2025, is accessible to existing and potential shareholders via the Investor Meet Company platform, allowing for pre-event and live questions, reflecting Anpario’s commitment to transparency and stakeholder engagement.

The most recent analyst rating on (GB:ANP) stock is a Buy with a £448.00 price target. To see the full list of analyst forecasts on Anpario stock, see the GB:ANP Stock Forecast page.

Anpario Announces New Share Allotment Under Employee Incentive Plan

Anpario has announced the allotment of 150,588 new ordinary shares to certain employees under its Employee’s Joint Share Ownership Plan (JSOP). These shares, issued at a subscription price of 395 pence each, are part of a strategy to incentivize employees, with the shares becoming vested if the employees remain with the company for a minimum of three years. This move is expected to strengthen employee retention and align their interests with the company’s growth, potentially impacting the company’s market positioning positively. The new shares will be admitted to trading on AIM, increasing the company’s total issued share capital to 20,595,829 ordinary shares, which could influence shareholder voting rights and interest notifications.

The most recent analyst rating on (GB:ANP) stock is a Buy with a £380.00 price target. To see the full list of analyst forecasts on Anpario stock, see the GB:ANP Stock Forecast page.

Anpario plc Approves Final Dividend at AGM

Anpario plc announced that all resolutions at their Annual General Meeting were passed, including the approval of a final dividend of 8.0p per ordinary share, to be distributed to shareholders on 25 July 2025. This decision reflects the company’s commitment to returning value to its shareholders and may positively impact investor confidence and market positioning.

The most recent analyst rating on (GB:ANP) stock is a Buy with a £380.00 price target. To see the full list of analyst forecasts on Anpario stock, see the GB:ANP Stock Forecast page.

Anpario plc Reports Strong First Half Sales and Strategic Global Expansion

Anpario plc reported strong sales performance in the first half of the year, driven by business development initiatives and improvements in the global agriculture market. Despite geopolitical uncertainties, the company’s diverse product and geographic portfolio are expected to mitigate potential adverse impacts. The company is preparing to launch several Bio-Vet products globally, with encouraging initial discussions and ongoing product registration. Financially, Anpario maintains a strong position with a cash balance of £9.0m, supporting continued growth opportunities.

The most recent analyst rating on (GB:ANP) stock is a Buy with a £380.00 price target. To see the full list of analyst forecasts on Anpario stock, see the GB:ANP Stock Forecast page.